Iradimed (IRMD) Cash from Investing Activities Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -253.01% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -11.91% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -41.67% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -6.88% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -472.46% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -16.93% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -111.03% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -40.94% |
| 10 | Iradimed | 1.17 Bn | 1.11 Bn | 16.81 Mn | 58.49% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 58.49% |
| Dec 31, 2025 | 4.07% |
| Sep 30, 2025 | -31.46% |
| Jun 30, 2025 | -237.40% |
| Mar 31, 2025 | -109.71% |
| Dec 31, 2024 | -139.67% |
| Sep 30, 2024 | -162.97% |
| Jun 30, 2024 | -53.57% |
| Mar 31, 2024 | -40.15% |
| Dec 31, 2023 | -60.13% |
| Sep 30, 2023 | -58.40% |
| Jun 30, 2023 | -49.13% |
| Mar 31, 2023 | -205.32% |
| Dec 31, 2022 | -35.80% |
| Sep 30, 2022 | -34.00% |
| Jun 30, 2022 | -38.86% |
| Mar 31, 2022 | -40.31% |
| Dec 31, 2021 | -37.70% |
| Sep 30, 2021 | -32.83% |
| Jun 30, 2021 | 57.41% |
| Mar 31, 2021 | -41.31% |
| Dec 31, 2020 | 30.03% |
| Sep 30, 2020 | -44.58% |
| Jun 30, 2020 | -21.33% |
| Mar 31, 2020 | -55.12% |
| Dec 31, 2019 | 52.79% |
| Sep 30, 2019 | 134.37% |
| Jun 30, 2019 | 38.13% |
| Mar 31, 2019 | 37.64% |
| Dec 31, 2018 | 94.95% |
| Sep 30, 2018 | 116.20% |
| Jun 30, 2018 | -68.43% |
| Mar 31, 2018 | 92.67% |
| Dec 31, 2017 | 42.64% |
| Sep 30, 2017 | -0.99% |
| Jun 30, 2017 | 65.90% |
| Mar 31, 2017 | -92.19% |
| Dec 31, 2016 | -128.72% |
| Sep 30, 2016 | 46.49% |